• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 12220
Device Problems No Apparent Adverse Event (3189); Insufficient Information (3190)
Patient Problems Hemolysis (1886); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/25/2024
Event Type  malfunction  
Event Description
The customer reported that there was a concentration of red blood cells in the plasma line detected during a therapeutic plasma exchange (tpe) procedure.Per the customer, the operator was able to confirm the interface, and while performing a red blood cell exchange a physician confirmed there was hemolysis of red cells.The operator disabled the red blood cell (rbc) detector and was able to complete the procedure.Patient information and outcome are unknown at this time.The platelet collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Lot number, manufacture, and expiry date are not available at this time.Investigation is in process and a follow up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.11.Investigation: lot number, manufacture, and expiry date are not available at this time.Further evaluation of this event has determined that the device did not cause or contribute to a death or serious injury, nor is there a likely potential for death or serious injury associated with this event based on additional investigational information.It was confirmed that the hemolysis was related to patient diagnosis.No further reporting will be provided as this does not represent a reportable event.
 
Event Description
The customer reported that there was a concentration of red blood cells in the plasma line detected during a therapeutic plasma exchange (tpe) procedure.Per the customer, the operator was able to confirm the interface, and while performing a red blood cell exchange a physician confirmed there was hemolysis of red cells.The operator disabled the red blood cell (rbc) detector and was able to complete the procedure.Patient information and outcome are unknown at this time.The platelet collection set is not available for return because it was discarded by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key18944578
MDR Text Key338360846
Report Number1722028-2024-00086
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number12220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/24/2024
Initial Date FDA Received03/20/2024
Supplement Dates Manufacturer Received05/08/2024
Supplement Dates FDA Received05/09/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-